Price $86.76 |
Market Cap
7.43B
|
Sector Health Care |
Div. Growth
12.00%
|
|
P/E
62.2
|
P/B
2.53
|
P/S
2.86
|
Dividend %
1.40%
|
|
P/CF
142.3
|
P/FCF
48.1
|
Op. Cash Flow
424.4K
|
FCF
1.8
|
|
Op. Margin
9.30%
|
Net Margin
4.60%
|
ROE
4.20%
|
ROI
3.60%
|
|
ROA
2.40%
|
EPS Growth
-14.50%
|
Current Ratio
2.7
|
Debt/Equity
52.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bioanalytical Systems, Inc. (BASI) | $1.72 | - | - | 12.6M | Strong Buy |
| Apollo Medical Holdings Inc (AMEH) | $9.75 | - | - | 50.1M | Strong Buy |
| Senomyx Inc. (SNMX) | $0.65 | - | - | 28.8M | Strong Buy |
| American Renal Associates Hold (ARA) | $15.21 | - | - | 448.3M | Strong Buy |
| CAS Medical Systems Inc (CASM) | $0.87 | - | - | 24.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
